We are poised to bridge the industry gap by delivering value-based products while maintaining focus on customer needs. We have state of the art R&D capability and market leading technology, 2 API manufacturing facilities armed with top of the line instruments with global approvals by USFDA, EDQM, NPRA etc. We stand by our vision to respect our partners through practicing the highest degree of professionalism by fostering individual accountability, reliability, continuous improvement, maintaining integrity and operational transparency, which we intend to achieve through developing utmost efficiency across the organization.
We recognize that trust is built incrementally project-by-project and we pride ourselves on the many deep, long-term customer relationships that underpin our business and demonstrate the value of the work we do.
Years of Excellence
in Macrolide Antibiotics
Evolution & Milestones
Commissioning of API manufacturing facility
Export Excellence Award from Ministry of Trade & Industry, Presented by Prime Minister of Malaysia
Awarded CEP for Erythromycin Base
Awarded CEP for Erythromycin stearate and Erythromycin ethylsuccinate
Awarded CEP for Clarithromycin
EUGMP Approval of our API Plant (through Bezirksregierung Münster)
Filed USDMF for Erythromycin base (DMF# 24956)
Asia Pacific International Entrepreneur Excellence Award
US FDA Approval of our API Plant
API-Australian TGA approval-Class-1
Filed USDMF for Erythromycin ethylsuccinate (DMF# 31754), Erythromycin base dihydrate (DMF# 32121) and Erythromycin stearate (DMF# 32120)
Awarded CEP for Erythromycin base dihydrate
Awarded GMP from NPRA, Malaysia (PIC/s member body) for newly commissioned Plant – II (Multipurpose manufacturing facility)
To be the first choice strategic partner for the pharmaceutical industry supplying Active Pharmaceutical Ingredients and advanced Intermediates based on innovation and robust technology without compromising on quality and affordability.
To make distinctive, eternal and substantial impact on the national, regional and global healthcare which can create global impact in manufacturing and supplying of quality medicines along with continous innovation in products and services.
SM Biomed’s manufacturing facility and products are approved by stringent regulatory bodies of the globe.
SM prides itself on supplying quality goods at the right price coupled with excellent service to all their customers. With over 30 years of industry experience and willingness to collaborate with strategic business partners across the globe has enabled the company to expand its supply & market base to over 60 countries spanning 5 continents from Asia to America.
Export Excellence Award
Ministry of international Trade and Industry, Malaysia
Asia Pacific Entrepreneur Excellence Award